Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedHistory now shows a new entry Revision: v3.6.6. The previous entry Revision: v3.6.5 has been removed.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a deployment of the latest platform version. No study data or history entries were modified.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new software release. This update does not modify any study data or the history content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe revision tag in the page footer updates from v3.6.2 to v3.6.3, signaling a new UI release without altering the study record content.SummaryDifference0.0%

- Check81 days agoChange DetectedA new site revision label v3.6.2 was added and the previous v3.6.0 entry was removed from the history display.SummaryDifference0.0%

- Check96 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', clarifying that the study is not enrolling. The revision label has updated to v3.6.0, with v3.5.5 removed.SummaryDifference0.1%

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.